Tobias Herold

University Hospital, LMU Munich

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Frederick Klauschen

Professor, Chair

Ludwig-Maximilians-Universität München

GERMANY

View details

Klaus Metzeler

Professor of Translational Hematology

Leipzig University

GERMANY

View details

Ulrich Mansmann

Ludwig-Maximilians-Universität München

GERMANY

View details

Christian Kellner

GERMANY

View details

Angelika Eggert

Full Professor of Pediatrics & Director

Charité - Universitätsmedizin Berlin

GERMANY

View details

Philipp Greif

University Hospital, LMU Munich

GERMANY

View details

Johannes Bagnoli

Institut de Recherche pour le Développement

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tobias Herold

Research Interests

Explore related searches

Contact this professor

Articles (10)

X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL

X-linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL

Lessons learned: the first consecutive 1000 patients of the CCCMunich(LMU) Molecular Tumor Board

Adverse stem cell clones within a single patient’s tumor predict clinical outcome in AML patients

Adverse stem cell clones within a single patient's tumor predict clinical outcome in AML patients

In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistance.

In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistance

Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages.

Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages

Do sophisticated models give the full picture of allogeneic hematopoietic stem cell transplantation effect?

Collaborators (7)

Frederick Klauschen

Klaus Metzeler

Ulrich Mansmann

Christian Kellner

Angelika Eggert

Philipp Greif

Johannes Bagnoli

Make your next move.